Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Myeloma

Trial MAGNETISMM-7
Cancer Type Haematological Cancers and Myeloma
Hospital(s) Belfast City Hospital
Information

A Randomized, 2-Arm, Phase 3 Study Of Elranatamab (Pf-06863135) Versus Lenalidomide In Patients With Newly Diagnosed Multiple Myeloma After Undergoing Autologous Stem-Cell Transplantation

Trial TALISMAN
Cancer Type Myeloma
Hospital(s) Belfast City Hospital
Information

A Phase 2, Open-Label, Randomised Study To Evaluate Prophylactic Interventions On Talquetamab-Related Oral Toxicity

Also in this Section